Gapping down
In reaction to disappointing earnings/guidance: IG -26.8%, (has submitted its second abbreviated New Drug Application of 2015 with the FDA; brings total pending ANDA submissions to 24 for the company ), INAP -18.5%, SSYS -18.1%, LL -15.6%, (also CFO Daniel Terrell will leave company and DOJ indicated it is seeking criminal charges under the Lacey Act with respect to laminate flooring allegations) GPRE -11.2%, WYNN -10.8%, (also cuts dividend), BWLD -10.2%, BLDP -9.8%, NVDQ -7.8%, OTEX -7%, RES -6.3%, AKAM -5.2%, X -4.4%, SLCA -3.6%, SAVE -3.6%, PNRA -3.3%, CRUS -3.2%, ARLP -3.1%, ULTI -3%, TWTR -2.6%, (late move lower on early earnings release), BBVA -2.3%, AFL -2.2%, AUY -2%, FARO -1.9%, WDC -1.9%,LINE -1.9%, ACGL -1.7%, FUN -1.5%, SO -1.3%, CALX -1.2%, AIZ -1%, (exploring strategic alternativces for employee benefits and health business segment; Provides Q1 Outlook), GRMN -1%, BMR -0.9%, KRFT -0.8%, PSEM -0.8%, WM -0.8%
Select metals/mining stocks trading lower: MT -3.3%, BHP -2.5%, BBL -2.2%, RIO -1.6%, FCX -1.4%
Other news: ASND -9.5% (announced results from Phase 1 study of TransCon Treprostinil, stating that injection-site tolerability issues did not meet the criteria defined in the target product profile), SVU -7.5% (Stephen Feinberg (Cerberus Capital) discloses 8.0% active stake in 13D filing; filing did not mention any plans to hold discussions with management), RES -6.3% (announces a reduction in its quarterly dividend to $0.05/share from $0.105/share), MGM -4.5% (following WYNN earnings/guidance), HASI -4.3% (announces commencement of a 4 mln share, public offering of common stock), BGS -4.1% (announces its intention to offer 4.2 mln shares of its common stock ), MPEL -4.1% (following WYNN earnings/guidance), DDD -4% (following SSYS guidance), LVS -4% (following WYNN earnings/guidance), ALQA -3.9% (announces proposed public offering of common stock), XONE -3.5% (following SSYS guidance), POST -1.5% (reported information regarding an avian influenza incident at one of its Michael Foods Group segment third party contracted egg suppliers), SO -1.3% (disclosed it will record pre-tax charge to income for the estimated probable losses on the Kemper IGCC of ~$5.6 mln after tax in Q1), LEAF -1.2% (upsizes and prices 27,864,525 shares of its common stock at a public offering price of $51.50 per share)
Analyst comments: AKS -1.9% (removed from Short-Term Buy List at Deutsche Bank), DB -1.4% (downgraded to Sell at Berenberg), GLW -1.1% (downgraded to Sell from Underperform at Credit Agricole)
In reaction to disappointing earnings/guidance: IG -26.8%, (has submitted its second abbreviated New Drug Application of 2015 with the FDA; brings total pending ANDA submissions to 24 for the company ), INAP -18.5%, SSYS -18.1%, LL -15.6%, (also CFO Daniel Terrell will leave company and DOJ indicated it is seeking criminal charges under the Lacey Act with respect to laminate flooring allegations) GPRE -11.2%, WYNN -10.8%, (also cuts dividend), BWLD -10.2%, BLDP -9.8%, NVDQ -7.8%, OTEX -7%, RES -6.3%, AKAM -5.2%, X -4.4%, SLCA -3.6%, SAVE -3.6%, PNRA -3.3%, CRUS -3.2%, ARLP -3.1%, ULTI -3%, TWTR -2.6%, (late move lower on early earnings release), BBVA -2.3%, AFL -2.2%, AUY -2%, FARO -1.9%, WDC -1.9%,LINE -1.9%, ACGL -1.7%, FUN -1.5%, SO -1.3%, CALX -1.2%, AIZ -1%, (exploring strategic alternativces for employee benefits and health business segment; Provides Q1 Outlook), GRMN -1%, BMR -0.9%, KRFT -0.8%, PSEM -0.8%, WM -0.8%
Select metals/mining stocks trading lower: MT -3.3%, BHP -2.5%, BBL -2.2%, RIO -1.6%, FCX -1.4%
Other news: ASND -9.5% (announced results from Phase 1 study of TransCon Treprostinil, stating that injection-site tolerability issues did not meet the criteria defined in the target product profile), SVU -7.5% (Stephen Feinberg (Cerberus Capital) discloses 8.0% active stake in 13D filing; filing did not mention any plans to hold discussions with management), RES -6.3% (announces a reduction in its quarterly dividend to $0.05/share from $0.105/share), MGM -4.5% (following WYNN earnings/guidance), HASI -4.3% (announces commencement of a 4 mln share, public offering of common stock), BGS -4.1% (announces its intention to offer 4.2 mln shares of its common stock ), MPEL -4.1% (following WYNN earnings/guidance), DDD -4% (following SSYS guidance), LVS -4% (following WYNN earnings/guidance), ALQA -3.9% (announces proposed public offering of common stock), XONE -3.5% (following SSYS guidance), POST -1.5% (reported information regarding an avian influenza incident at one of its Michael Foods Group segment third party contracted egg suppliers), SO -1.3% (disclosed it will record pre-tax charge to income for the estimated probable losses on the Kemper IGCC of ~$5.6 mln after tax in Q1), LEAF -1.2% (upsizes and prices 27,864,525 shares of its common stock at a public offering price of $51.50 per share)
Analyst comments: AKS -1.9% (removed from Short-Term Buy List at Deutsche Bank), DB -1.4% (downgraded to Sell at Berenberg), GLW -1.1% (downgraded to Sell from Underperform at Credit Agricole)